Closing Gaps in STI Care Through Molecular Point-of-Care Testing
Molecular point-of-care testing has the potential to substantially mitigate the impact of sexually transmitted infections (STIs) on personal and public health. Listen in to learn how it may even limit...
2 Des 202510min
Testing Is Treatment: The Power of Routine HIV Screening
The crux of HIV care and prevention is quick and accurate diagnosis. Listen in to learn from Aniruddha (Anu) Hazra, MD, and Dr. Nancy S. Miller about the advantages and potential pitfalls of different...
2 Des 202516min
Optimizing Antibiotics in Acute Bacterial Skin and Skin Structure Infections for Today
Listen in as experts Thomas P. Lodise, PharmD, PhD, and George Sakoulas, MD, FIDSA, explore tailored antibiotic strategies for diverse patients with acute bacterial skin and skin structure infections ...
26 Nov 202545min
Overcoming Misconceptions About Candidacy for Switch: Barriers to Optimizing ART in People Living With HIV and Viral Suppression
Look beyond viral suppression to learn how people living with virologically suppressed HIV may still be candidates for antiretroviral therapy (ART) switch to improve treatment satisfaction and quality...
25 Nov 202531min
Modern S. maltophilia Management: Current Concepts for Best Outcomes
Join Ryan K. Shields, PharmD, MS, in the third of 3 podcasts from our live event, “The Plot (and Sputum) Thickens: Encountering Carbapenem Resistance in Critically Ill Patients” to learn how to optimi...
25 Nov 20259min
Carbapenem Resistance Revisited: Reassessing Our Antibiotics of Choice
Join Marin H. Kollef, MD in the first of 3 podcasts from our live event, “The Plot (and Sputum) Thickens: Encountering Carbapenem Resistance in Critically Ill Patients” to learn how to optimize antimi...
25 Nov 202514min
DTR-P. aeruginosa: Pathways to Overcoming Diverse Resistance Profiles
Join Ryan K. Shields, PharmD, MS, in the second of three recap podcasts taken from our live event, “The Plot (and Sputum) Thickens: Encountering Carbapenem Resistance in Critically Ill Patients.” Lear...
25 Nov 202519min
Overcoming Fear of Virologic Failure: Barriers to Optimizing ART in People Living With HIV and Viral Suppression
Fear of virologic failure is a major barrier to ensuring that people living with virally suppressed HIV are receiving the most optimal antiretroviral therapy (ART) regimen for them. Stream this Medica...
21 Nov 202518min
